deferiprone has been researched along with Stunted Growth in 3 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dental caries were significantly higher in thalassemics." | 1.33 | Physical growth patterns and dental caries in thalassemia. ( Dewan, P; Gomber, S, 2006) |
| "A male thalassemia major patient who developed bone and cartilage abnormalities with a standard dose of desferrioxamine (DFX) given subcutaneously from the age of 4 years was treated with the oral iron chelator deferiprone (L1)." | 1.31 | Treatment with deferiprone (L1) in a thalassemic patient with bone lesions due to desferrioxamine. ( Campisi, S; De Sanctis, V; Di Silvestro, G; Mangiagli, A; Urso, L, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomber, S | 1 |
| Dewan, P | 1 |
| Mangiagli, A | 1 |
| De Sanctis, V | 1 |
| Campisi, S | 1 |
| Di Silvestro, G | 1 |
| Urso, L | 1 |
| Taher, A | 1 |
| Sheikh-Taha, M | 1 |
| Koussa, S | 1 |
| Inati, A | 1 |
| Neeman, R | 1 |
| Mourad, F | 1 |
1 trial available for deferiprone and Stunted Growth
| Article | Year |
|---|---|
Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients.
Topics: Administration, Oral; Adolescent; Adult; beta-Thalassemia; Chelation Therapy; Child; Deferiprone; De | 2001 |
2 other studies available for deferiprone and Stunted Growth
| Article | Year |
|---|---|
Physical growth patterns and dental caries in thalassemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Deferiprone; Deferoxamine; Dental Caries; Female; Ferrit | 2006 |
Treatment with deferiprone (L1) in a thalassemic patient with bone lesions due to desferrioxamine.
Topics: beta-Thalassemia; Body Height; Bone Diseases; Deferiprone; Deferoxamine; Growth Disorders; Humans; I | 2000 |